“…Previous reviews and a recent study comparing rates of symptom exacerbation and side effects across 4 fixed doses of haloperidol decanoate support our recommendation of administering 50-200 mg of this medication once monthly. 1,51,52 In the study by Kane and colleagues, 52 rates of symptom exacerbation were significantly higher for participants randomized to monthly administration of 25 mg (60%) of haloperidol decanoate compared with those who received 50 (25%), 100 (23%), or 200 (15%). There were no differences in adverse effects, including EPS, among participants receiving the 3 higher doses of haloperidol decanoate.…”